Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood 2017-03, Vol.129 (10), p.1397-1401
Hauptverfasser:	Duncavage, Eric J., Uy, Geoffrey L., Petti, Allegra A., Miller, Christopher A., Lee, Yi-Shan, Tandon, Bevan, Gao, Feng, Fronick, Catrina C., O'Laughlin, Michelle, Fulton, Robert S., Wilson, Richard K., Jacoby, Meagan A., Cashen, Amanda F., Wartman, Lukas D., Walter, Matthew J., Westervelt, Peter, Link, Daniel C., DiPersio, John F., Ley, Timothy J., Welch, John S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Azacitidine - administration & dosage Azacitidine - analogs & derivatives Blood Cells - metabolism Blood Cells - pathology Decitabine Female Humans Letter to Leukemia, Myeloid, Acute - blood Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - genetics Leukemia, Myeloid, Acute - pathology Male Mutation Myelodysplastic Syndromes - blood Myelodysplastic Syndromes - drug therapy Myelodysplastic Syndromes - genetics Myelodysplastic Syndromes - pathology Neoplasm Proteins - blood Neoplasm Proteins - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!